SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-021961
Filing Date
2022-08-11
Accepted
2022-08-11 07:02:26
Documents
15
Period of Report
2022-08-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 53549
2 ex10-1.htm EX-10.1 27982
3 ex99-1.htm EX-99.1 65139
  Complete submission text file 0001493152-22-021961.txt   386786

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cing-20220809.xsd EX-101.SCH 3718
5 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cing-20220809_def.xml EX-101.DEF 26635
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cing-20220809_lab.xml EX-101.LAB 36718
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cing-20220809_pre.xml EX-101.PRE 25259
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5585
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40874 | Film No.: 221153619
SIC: 2834 Pharmaceutical Preparations